Artgen Biotech PJSC (MOEX:ISKJ)
Russia · Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Cash Flow Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 96.95 | 214.91 | 168.86 | 46.12 | 11.63 |
Depreciation & Amortization | 142.08 | 84.35 | 70.9 | 53.48 | 79.84 |
Other Amortization | - | 0.36 | - | - | 1.44 |
Loss (Gain) From Sale of Assets | 0.92 | -0.52 | 0.58 | 75.31 | 26.51 |
Loss (Gain) on Equity Investments | 25.97 | 3.5 | 24.17 | -23.14 | 5.21 |
Provision & Write-off of Bad Debts | 8.29 | 11.98 | 13.43 | 15.41 | 12.73 |
Other Operating Activities | 25.52 | 234.66 | 112.13 | 84.91 | 99.99 |
Change in Accounts Receivable | -153.54 | -28.52 | -92.46 | 86.7 | 8.72 |
Change in Inventory | 22.13 | -21.58 | -1.51 | 16.4 | -21.54 |
Change in Accounts Payable | 22.43 | -17.32 | 138.75 | -134.9 | 56.27 |
Operating Cash Flow | 190.75 | 481.83 | 434.85 | 220.3 | 280.8 |
Operating Cash Flow Growth | -60.41% | 10.80% | 97.39% | -21.55% | 421.32% |
Capital Expenditures | -170.39 | -99.68 | -204.29 | -135.93 | -153.3 |
Cash Acquisitions | -25.58 | -4.88 | - | -78.96 | - |
Investment in Securities | -5.18 | -0.17 | -46.86 | -66.1 | -71.49 |
Other Investing Activities | 59.5 | 52.55 | 27.04 | 5.48 | 6.12 |
Investing Cash Flow | -288.25 | -171.31 | -216.97 | -346.78 | -252.25 |
Long-Term Debt Issued | 300 | - | - | 196 | 319.23 |
Long-Term Debt Repaid | -70.4 | -122.78 | -83.76 | -14.19 | -194.64 |
Net Debt Issued (Repaid) | 229.6 | -122.78 | -83.76 | 181.81 | 124.59 |
Issuance of Common Stock | 14.12 | - | 38.89 | 43.8 | 3.49 |
Repurchase of Common Stock | - | -35.96 | - | - | - |
Common Dividends Paid | -56.21 | -140.69 | -104.23 | - | - |
Other Financing Activities | -29.68 | -47.31 | 274.03 | -87.3 | -69.11 |
Financing Cash Flow | 157.83 | -346.74 | 124.94 | 138.31 | 58.96 |
Foreign Exchange Rate Adjustments | 1.69 | -5.38 | 0.46 | -3.46 | -1.61 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
Net Cash Flow | 62.02 | -41.59 | 343.28 | 8.37 | 85.9 |
Free Cash Flow | 20.36 | 382.16 | 230.56 | 84.37 | 127.51 |
Free Cash Flow Growth | -94.67% | 65.75% | 173.26% | -33.83% | - |
Free Cash Flow Margin | 1.19% | 25.12% | 16.85% | 7.42% | 10.80% |
Free Cash Flow Per Share | 0.27 | 4.13 | 2.49 | 0.97 | 1.59 |
Cash Interest Paid | - | 91.35 | 52.1 | 48.6 | 50.71 |
Cash Income Tax Paid | - | 5.8 | 24.64 | 3.83 | 5.71 |
Levered Free Cash Flow | -294.76 | 158.46 | -28.18 | -139.31 | -12.27 |
Unlevered Free Cash Flow | -238.67 | 217.87 | 2.59 | -96.92 | 19.4 |
Change in Working Capital | -108.98 | -67.42 | 44.78 | -31.79 | 43.46 |